Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...

The report provides a comprehensive analysis of the genome editing market, focusing on technologies like CRISPR-Cas, TALEN, ...

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

Precision BioSciences (DTIL) announced the publication of a peer-reviewed manuscript titled “High-Efficiency Homology-Directed Insertion into the ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived toolbox. Metagenomi is ...

This study is led by Professor Yongming Wang's research team from Fudan University, in collaboration with the team led by Professor Renjie Chai from Southeast University. This study is published in a ...

- Additional Data at ASGCT Annual Meeting Demonstrate Precision of HR-Based Approach with Genome-Wide Integration Assays Confirming On-Target Editing and No Off-Target Events - - New Data from GTx-mAb ...

CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are finding other ways in.

Genome editing is increasingly recognized as a leading frontier in biomedical research and an essential driver of healthcare innovation.

Delivering genome editing machinery into plant cells remains a challenge despite the dire need for high yield crops with enhanced nutritional value that are resistant to disease and resilient in the ...